Jazz Pharmaceuticals Files 8-K
Ticker: JAZZ · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, listing-information
Related Tickers: JAZZ
TL;DR
JAZZ filed an 8-K on Jan 13, 2025, confirming its Nasdaq listing and Irish incorporation.
AI Summary
On January 13, 2025, Jazz Pharmaceuticals plc (JAZZ) filed a Form 8-K to report its status as a public company. The filing confirms the company's incorporation in Ireland and lists its principal executive offices in Dublin. It also details the trading symbol 'JAZZ' and the exchange, The Nasdaq Stock Market LLC, where its ordinary shares are registered.
Why It Matters
This routine filing provides essential corporate information and confirms the listing details for Jazz Pharmaceuticals on the Nasdaq, which is important for investors and market participants.
Risk Assessment
Risk Level: low — This is a standard corporate filing that does not contain new material financial or operational information.
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- JAZZ (company) — Trading Symbol
- The Nasdaq Stock Market LLC (company) — Exchange
- Ireland (location) — State or Other Jurisdiction of Incorporation
- Dublin (location) — Address of principal executive offices
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report current information as required by the Securities and Exchange Commission, specifically confirming the company's corporate details and listing information.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing occurred on January 13, 2025.
Where is Jazz Pharmaceuticals plc incorporated?
Jazz Pharmaceuticals plc is incorporated in Ireland.
What is the trading symbol for Jazz Pharmaceuticals' ordinary shares?
The trading symbol for Jazz Pharmaceuticals' ordinary shares is JAZZ.
On which stock exchange are Jazz Pharmaceuticals' ordinary shares registered?
Jazz Pharmaceuticals' ordinary shares are registered on The Nasdaq Stock Market LLC.
Filing Stats: 568 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-01-13 07:45:56
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d699726d8k.htm (8-K) — 24KB
- d699726dex991.htm (EX-99.1) — 37KB
- g699726ex99_1p10g1.jpg (GRAPHIC) — 319KB
- g699726ex99_1p11g1.jpg (GRAPHIC) — 322KB
- g699726ex99_1p12g1.jpg (GRAPHIC) — 267KB
- g699726ex99_1p13g1.jpg (GRAPHIC) — 231KB
- g699726ex99_1p14g1.jpg (GRAPHIC) — 326KB
- g699726ex99_1p15g1.jpg (GRAPHIC) — 303KB
- g699726ex99_1p16g1.jpg (GRAPHIC) — 349KB
- g699726ex99_1p17g1.jpg (GRAPHIC) — 339KB
- g699726ex99_1p18g1.jpg (GRAPHIC) — 449KB
- g699726ex99_1p19g1.jpg (GRAPHIC) — 384KB
- g699726ex99_1p1g1.jpg (GRAPHIC) — 329KB
- g699726ex99_1p20g1.jpg (GRAPHIC) — 334KB
- g699726ex99_1p21g1.jpg (GRAPHIC) — 360KB
- g699726ex99_1p22g1.jpg (GRAPHIC) — 308KB
- g699726ex99_1p23g1.jpg (GRAPHIC) — 260KB
- g699726ex99_1p24g1.jpg (GRAPHIC) — 274KB
- g699726ex99_1p25g1.jpg (GRAPHIC) — 330KB
- g699726ex99_1p26g1.jpg (GRAPHIC) — 164KB
- g699726ex99_1p27g1.jpg (GRAPHIC) — 169KB
- g699726ex99_1p2g1.jpg (GRAPHIC) — 580KB
- g699726ex99_1p3g1.jpg (GRAPHIC) — 382KB
- g699726ex99_1p4g1.jpg (GRAPHIC) — 282KB
- g699726ex99_1p5g1.jpg (GRAPHIC) — 267KB
- g699726ex99_1p6g1.jpg (GRAPHIC) — 390KB
- g699726ex99_1p7g1.jpg (GRAPHIC) — 269KB
- g699726ex99_1p8g1.jpg (GRAPHIC) — 198KB
- g699726ex99_1p9g1.jpg (GRAPHIC) — 253KB
- 0001193125-25-004989.txt ( ) — 11826KB
- jazz-20250113.xsd (EX-101.SCH) — 3KB
- jazz-20250113_lab.xml (EX-101.LAB) — 18KB
- jazz-20250113_pre.xml (EX-101.PRE) — 11KB
- d699726d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Presentation slides by Jazz Pharmaceuticals plc on January 14, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/ Philip L. Johnson Name: Philip L. Johnson Title: Executive Vice President and Chief Financial Officer Date: January 13, 2025